Pulmonary IDO activity was lower in patients with allergic asthma. Systemic tryptophan and its catabolites were higher in these patients. Systemic quinolinic acid and tryptophan were associated with ECP and eosinophils in BAL fluid and peak asthma symptom scores after the RV challenge. This evidence concerns the gene IDO1 and asthma.